Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,584
Total Claims
$962K
Drug Cost
818
Beneficiaries
$1,177
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
-17%
Cost per patient vs peers
$1,177 vs $1,411 avg
+17%
Brand preference vs peers
12.4% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$32
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,181 claims · $782K
Generic: 8,338 claims · $177K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 158 | $191K |
| Dulaglutide | 61 | $83K |
| Apixaban | 88 | $80K |
| Dapagliflozin Propanediol | 70 | $69K |
| Empagliflozin | 21 | $32K |
| Fluticasone/Umeclidin/Vilanter | 28 | $26K |
| Mirabegron | 27 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $17K |
| Tirzepatide | 14 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $12K |
| Fluticasone/Vilanterol | 16 | $9,286 |
| Fluticasone Propion/Salmeterol | 16 | $8,857 |
| Galcanezumab-Gnlm | 12 | $8,818 |
| Insulin Detemir | 13 | $8,497 |
| Rosuvastatin Calcium | 449 | $6,215 |
Prescribing Profile
Patient Profile
75
Avg Age
77%
Female
0.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data